Pulmonx Corp. (LUNG) PT Raised to $12 at Citi, Downgraded From Buy-High Risk to Buy
Citi analyst Joanne Wuensch raised the price target on Pulmonx Corp. (NASDAQ: LUNG) to $12.00 (from $10.00) while maintaining a ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
